EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Hendrika A Segeren, Kathryn A Wierenga iD, Frank M Riemers iD, Elsbeth A van Liere, Bart Westendorp iD

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.13819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Hendrika A Segeren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, DNA Replication, Transcription, Genetic, Stress, Physiological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncogene‐induced replication stress (RS) is a vulnerability of cancer cells that forces reliance on the intra‐S‐phase checkpoint to ensure faithful genome duplication. Inhibitors of the intra‐S‐phase checkpoint kinases ATR and CHK1 have been developed, but resistance to these drugs remains problematic. Understanding drug tolerance mechanisms is impeded by analysis of bulk samples, which neglect tumor heterogeneity and often fail to accurately interpret cell cycle‐mediated resistance. Here, by combining intracellular immunostaining and single‐cell RNA‐sequencing, we characterized the transcriptomes of oncogenic RAS‐expressing cells with variable levels of RS when challenged with a CHK1 inhibitor combined with gemcitabine. We identified 37 genes differentially expressed between tolerant and sensitive cells, including several FOXM1 targets. While complete knockdown of FOXM1 impeded cell proliferation, partial knockdown protected cells against DNA damage, and improved recovery from drug‐induced RS. Remarkably, knockdown of individual FOXM1 target genes UBE2C and MKI67 also mitigated DNA damage, uncovering unanticipated roles for these in the replication stress response. Our results suggest that low levels of FOXM1‐dependent gene expression during S and G2 phase protects cells against excessive DNA damage during drug‐induced replication stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein M1DNA ReplicationTranscription, GeneticStress, PhysiologicalHumansCell Line, TumorDNA DamageGemcitabineCheckpoint Kinase 1Gene Expression Regulation, NeoplasticDeoxycytidineCell Proliferation

Stichwörter der Autor:innen

CHK1FOXM1gemcitabineoncogenic RASreplication stresssingle‐cell RNA‐sequencing

Substanzen

Forkhead Box Protein M1FOXM1 protein, humanGemcitabineCheckpoint Kinase 1Deoxycytidine

Autor:innen und Institutionen

  • Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

ORCID-Profile: Kathryn A Wierenga, Frank M Riemers, Bart Westendorp

Förderung

  • KWF Kankerbestrijding
  • ZonMw

Zitieren

APA

Segeren, H. A., Wierenga, K. A., Riemers, F. M., van Liere, E. A., & Westendorp, B. (2025). Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance. Molecular Oncology. https://doi.org/10.1002/1878-0261.13819

Vancouver

Segeren HA, Wierenga KA, Riemers FM, van Liere EA, Westendorp B. Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance. Molecular Oncology. 2025. doi:10.1002/1878-0261.13819

BibTeX
@article{Segeren2025,
  author = {Segeren, Hendrika A and Wierenga, Kathryn A and Riemers, Frank M and van Liere, Elsbeth A and Westendorp, Bart},
  title = {Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.13819}
}
Kostenlos starten →